Precipio Current Ratio 2012-2026 | PRPO
Precipio current ratio from 2012 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Precipio Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2026-06-30 | $0.01B | $0.00B | 1.77 |
| 2026-03-31 | $0.01B | $0.00B | 1.56 |
| 2025-12-31 | $0.01B | $0.00B | 1.61 |
| 2025-09-30 | $0.01B | $0.00B | 1.27 |
| 2025-06-30 | $0.00B | $0.00B | 0.93 |
| 2025-03-31 | $0.00B | $0.00B | 0.76 |
| 2024-12-31 | $0.00B | $0.00B | 0.81 |
| 2024-09-30 | $0.00B | $0.00B | 0.73 |
| 2024-06-30 | $0.00B | $0.01B | 0.73 |
| 2024-03-31 | $0.00B | $0.00B | 0.78 |
| 2023-12-31 | $0.00B | $0.00B | 1.17 |
| 2023-09-30 | $0.00B | $0.01B | 0.79 |
| 2023-06-30 | $0.00B | $0.01B | 0.92 |
| 2023-03-31 | $0.00B | $0.01B | 0.89 |
| 2022-12-31 | $0.01B | $0.00B | 1.31 |
| 2022-09-30 | $0.01B | $0.00B | 1.68 |
| 2022-06-30 | $0.01B | $0.00B | 2.19 |
| 2022-03-31 | $0.01B | $0.00B | 2.59 |
| 2021-12-31 | $0.01B | $0.00B | 3.20 |
| 2021-09-30 | $0.02B | $0.00B | 4.14 |
| 2021-06-30 | $0.02B | $0.00B | 4.67 |
| 2021-03-31 | $0.00B | $0.00B | 0.92 |
| 2020-12-31 | $0.00B | $0.01B | 0.90 |
| 2020-09-30 | $0.00B | $0.00B | 0.89 |
| 2020-06-30 | $0.00B | $0.01B | 0.43 |
| 2020-03-31 | $0.00B | $0.01B | 0.25 |
| 2019-12-31 | $0.00B | $0.00B | 0.43 |
| 2019-09-30 | $0.00B | $0.01B | 0.64 |
| 2019-06-30 | $0.00B | $0.01B | 0.49 |
| 2019-03-31 | $0.00B | $0.01B | 0.14 |
| 2018-12-31 | $0.00B | $0.01B | 0.13 |
| 2018-09-30 | $0.00B | $0.01B | 0.14 |
| 2018-06-30 | $0.00B | $0.01B | 0.13 |
| 2018-03-31 | $0.00B | $0.01B | 0.14 |
| 2017-12-31 | $0.00B | $0.01B | 0.17 |
| 2017-09-30 | $0.00B | $0.01B | 0.08 |
| 2017-06-30 | $0.00B | $0.02B | 0.11 |
| 2017-03-31 | $0.00B | $0.02B | 0.03 |
| 2016-12-31 | $0.00B | $0.00B | 0.18 |
| 2016-09-30 | $0.00B | $0.02B | 0.05 |
| 2016-06-30 | $0.00B | $0.02B | 0.10 |
| 2016-03-31 | $0.00B | $0.02B | 0.12 |
| 2015-12-31 | $0.00B | $0.02B | 0.19 |
| 2015-09-30 | $0.02B | $0.02B | 1.00 |
| 2015-06-30 | $0.02B | $0.01B | 1.16 |
| 2015-03-31 | $0.02B | $0.01B | 1.65 |
| 2014-12-31 | $0.03B | $0.01B | 2.38 |
| 2014-09-30 | $0.01B | $0.01B | 1.40 |
| 2014-06-30 | $0.01B | $0.01B | 1.37 |
| 2014-03-31 | $0.01B | $0.01B | 1.58 |
| 2013-12-31 | $0.01B | $0.01B | 1.37 |
| 2013-09-30 | $0.01B | $0.01B | 1.58 |
| 2013-06-30 | $0.02B | $0.01B | 2.52 |
| 2013-03-31 | $0.02B | $0.01B | 2.27 |
| 2012-12-31 | $0.02B | $0.02B | 1.23 |
| 2012-09-30 | $0.02B | $0.02B | 1.36 |
| 2012-06-30 | $0.03B | $0.02B | 1.95 |
| 2012-03-31 | $0.03B | $0.02B | 1.99 |
| 2011-12-31 | $0.02B | $0.02B | 1.05 |
| 2011-09-30 | $0.01B | $0.01B | 1.35 |
| 2011-06-30 | $0.01B | $0.01B | 1.41 |
| 2011-03-31 | $0.02B | $0.01B | 1.76 |
| 2010-12-31 | $0.02B | $0.01B | 1.82 |
| 2010-09-30 | $0.01B | $0.00B | 2.91 |
| 2010-06-30 | $0.01B | $0.00B | 3.06 |
| 2010-03-31 | $0.02B | $0.01B | 3.02 |
| 2009-12-31 | $0.01B | $0.00B | 3.52 |
| 2009-09-30 | $0.01B | $0.00B | 3.71 |
| 2009-06-30 | $0.01B | $0.00B | 3.52 |
| 2009-03-31 | $0.02B | $0.00B | 3.34 |
| 2008-12-31 | $0.02B | $0.00B | 3.68 |
| 2008-09-30 | $0.02B | $0.00B | 3.76 |
| 2008-06-30 | $0.02B | $0.01B | 3.57 |
| 2008-03-31 | $0.02B | $0.01B | 3.13 |
| 2007-12-31 | $0.02B | $0.01B | 3.34 |
| 2007-09-30 | $0.02B | $0.01B | 2.74 |
| 2007-06-30 | $0.02B | $0.01B | 3.30 |
| 2007-03-31 | $0.02B | $0.01B | 3.27 |
| 2006-12-31 | $0.02B | $0.01B | 2.93 |
| 2006-09-30 | $0.02B | $0.01B | 3.02 |
| 2006-06-30 | $0.02B | $0.01B | 2.79 |
| 2006-03-31 | $0.02B | $0.01B | 2.48 |
| 2005-12-31 | $0.02B | $0.01B | 2.44 |
| 2005-09-30 | $0.02B | $0.02B | 1.09 |
| 2005-06-30 | $0.02B | $0.02B | 1.01 |
| 2005-03-31 | $0.02B | $0.02B | 1.05 |
| 2004-12-31 | $0.02B | $0.02B | 0.96 |
| 2004-09-30 | $0.02B | $0.02B | 1.12 |
| 2004-06-30 | $0.03B | $0.02B | 1.72 |
| 2004-03-31 | $0.03B | $0.01B | 2.16 |
| 2003-12-31 | $0.02B | $0.01B | 1.99 |
| 2003-09-30 | $0.03B | $0.01B | 2.25 |
| 2003-06-30 | $0.03B | $0.01B | 2.63 |
| 2003-03-31 | $0.03B | $0.01B | 2.78 |
| 2002-12-31 | $0.04B | $0.01B | 3.55 |
| 2002-09-30 | $0.05B | $0.01B | 5.71 |
| 2002-06-30 | $0.05B | $0.01B | 6.26 |
| 2002-03-31 | $0.06B | $0.01B | 6.95 |
| 2001-12-31 | $0.06B | $0.01B | 8.76 |
| 2001-09-30 | $0.06B | $0.01B | 9.87 |
| 2001-06-30 | $0.07B | $0.01B | 9.05 |
| 2001-03-31 | $0.07B | $0.00B | 15.42 |
| 2000-12-31 | $0.07B | $0.00B | 18.04 |
| 2000-09-30 | $0.08B | $0.01B | 11.19 |
| 2000-06-30 | $0.01B | $0.01B | 1.01 |
| 2000-03-31 | $0.01B | $0.01B | 1.22 |
| 1999-12-31 | $0.01B | $0.01B | 1.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.049B | $0.024B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |